Do you think the new classification criteria for IgG4-RD will increase the inclusion of people with IgG4-RD in clinical trials and observational studies? Let us know by taking the poll.
Cognitive changes are common among people with multiple sclerosis (MS). How do you screen for cognitive involvement among your patients with MS? Let us know by taking our poll.